How Wegovy Compares to Other GLP-1 Options in Michigan | Medication | Active ingredient | Monthly list price (2026) | Indication | |---|---|---|---| | Wegovy 2.4 mg | Semaglutide | $1,349 | Chronic weight management | | Ozempic 2 mg | Semaglutide | $935 | Type 2 diabetes (off-label for weight) | | Mounjaro 15 mg | Tirzepatide | $1,023 | Type 2 diabetes (off-label for weight) | | Zepbound 15 mg | Tirzepatide | $1,059 | Chronic weight management | | Saxenda | Liraglutide 3 mg | $1,415 | Chronic weight management | Ozempic and Mounjaro are approved for type 2 diabetes, not chronic weight management
Cell Rep
How the savings card works with commercial insurance If you have commercial (employer-sponsored or private) insurance and your plan covers the semaglutide medication youre prescribed, the manufacturers savings card can bring your monthly cost down to as low as $25 per month
The Cleveland Clinic Journal of Medicine also highlights that while GLP1 receptor agonists are effective for diabetes and weight loss, they may slightly increase the health risk of drug-induced pancreatitis If you or a loved one developed severe pancreatitis after taking Ozempic, you may be eligible to file an Ozempic lawsuit
Frequently Asked Questions Cigna's drug benefit runs through Express Scripts, whose 2026 National Preferred Formulary excludes Wegovy injection and Wegovy tablets for weight loss on the base plan Zepbound vials are the preferred weight-loss GLP-1
Both contain semaglutide, but their strengths, administration, absorption, indication details, risk-reduction language, and switching instructions differ
